Skandinaviska Enskilda Banken (SEB)
AKCA

Skandinaviska Enskilda Banken (SEB)’s Akcea Therapeutics Inc AKCA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,800
Closed -$189K – 1149
2020
Q2 		$189K Sell
13,800
-45,500
-77% -$702K ﹤0.01% 920
2020
Q1 		$848K Buy
+59,300
New +$973K 0.01% 676

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AKCA Position: Q3 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Akcea Therapeutics Inc (AKCA) in Q3 2020, closing a stake of 13,800 shares — an estimated $189K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AKCA in Q1 2020 and held it in 2 quarters. The position peaked at $848K in Q1 2020. 98 funds tracked by Wall St. Rank hold AKCA as of Q3 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Akcea Therapeutics Inc position as of Q3 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 13,800 Akcea Therapeutics Inc shares in Q3 2020, an estimated $189K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Akcea Therapeutics Inc in Q1 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Akcea Therapeutics Inc position peaked at $848K in Q1 2020.
  • 98 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2020, filed 12 Nov 2020.